Cost-utility analysis evaluating lidocaine 5% medicated plaster relative to gabapentin for postherpetic neuralgia in Scotland by Dakin, H, Nuijten, M, Liedgens, H, Poulsen, N

Cost-effectiveness of a lidocaine plaster relative to pregabalin in the treatment of post-herpetic neuralgia in Scotland by Dakin, H, Nuijten, M, Poulsen, N, Liedgens, H

Cost-Effectiveness of a Lidocaine 5% Medicated Plaster Relative to Gabapentin for Postherpetic Neuralgia in the United Kingdom by Dakin, H, Nuijten, M, Liedgens, H, Nautrup, B

Health economics evidence for medical nutrition: are these interventions value for money in integrated care? by Walzer S, Droeschel D, Nuijten M, Chevrou-Séverac H

Get full text

Nutrition economic evaluation of a probiotic in the prevention of antibiotic-associated diarrhea by Lenoir-Wijnkoop, I, Nuijten, M, Craig, J, Butler, C

A Meal Replacement Program for the Treatment of Obesity: A Cost-Effectiveness Analysis from the Swiss Payer’s Perspective by Nuijten M, Dainelli L, Rasouli B, Araujo Torres K, Perugini M, Marczewska A

Get full text

Cost-effectiveness analysis of a lidocaine 5% medicated plaster compared with gabapentin and pregabalin for treating postherpetic neuralgia: a german perspective. by Liedgens, H, Hertel, N, Gabriel, A, Nuijten, M, Dakin, H, Mitchell, S, Nautrup, B

Cost-effectiveness analysis of the lidocaine 5% medicated plaster relative to gabapentin and pregabalin for post-herpetic neuralgia in Germany by Liedgens, H, Hertel, N, Gabriel, A, Nuijten, M, Dakin, H, Spoehrer, U, Poulsen Nautrup, B

Costutility analysis evaluating the lidocaine 5% medicated plaster relative to gabapentin and pregabalin for postherpetic neuralgia in Germany by Liedgens, H, Hertel, N, Gabriel, A, Nuijten, M, Dakin, H, Sphrer, U, Poulsen Nautrup, B